About Pathology AI & Oncology
The Pathology AI & Oncology category is part of the AI in Healthcare market map, tracking 13 companies building in this segment. Diagnostics, medical imaging, clinical AI, and remote monitoring transforming patient outcomes and healthcare delivery. Curated by Hartmann Capital's venture research team.
Companies in Pathology AI & Oncology
- PathAI — Series C, $240M
- Paige — Series C, $225M
- Proscia — Series C, $130M
- Ibex Medical Analytics — Series C, $100M
- Tempus AI — Public, $1.3B
- Guardant Health — Public, $738M
- Freenome — Series D, $854M
- Grail — Acquired, $2B
- Veracyte — Public
- Aiforia — Series B, $21M
- Visiopharm — Growth
- Aignostics — Series A, $34M
- Owkin — Series B, $334M
Frequently Asked Questions
- What companies are in the Pathology AI & Oncology category?
- The Pathology AI & Oncology category includes 13 companies: PathAI, Paige, Proscia, Ibex Medical Analytics, Tempus AI, Guardant Health, Freenome, Grail, Veracyte, Aiforia, Visiopharm, Aignostics, Owkin. This is part of the AI in Healthcare market map maintained by Hartmann Capital.
- How many Pathology AI & Oncology startups are tracked?
- Hartmann Capital tracks 13 companies in the Pathology AI & Oncology segment of the AI in Healthcare market map.
- What are the best funded Pathology AI & Oncology companies?
- Top funded companies in Pathology AI & Oncology include Grail ($2000M), Tempus AI ($1300M), Freenome ($854M), Guardant Health ($738M), Owkin ($334M). Browse the full list in the AI in Healthcare market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.